Books: The Immortal Life of Henrietta Lacks

Get your news from a source that’s not owned and controlled by oligarchs. Sign up for the free Mother Jones Daily.


When Henrietta Lacks—a poor, African American tobacco farmer from Virginia—checked into Johns Hopkins Hospital with cervical cancer in 1951, she had no idea that tissue removed from her body without her consent would become one of the most important resources in medical history. She died soon afterward, but her cells, dubbed HeLa, astonished scientists with their still-mysterious “immortality”—they were the first ones to survive indefinitely in the lab, and reproduced at an unprecedented rate. HeLa provided the raw material necessary to develop the polio vaccine and many other medical breakthroughs. In this gripping, vibrant book, Rebecca Skloot looks beyond the scientific marvels to explore the ethical issues behind a discovery that may have saved your life.

Skloot pinpoints HeLa as the origin of many ethical debates that still define modern science, tissue research, and the ownership of the body. Since learning about HeLa in 1973, Lacks’ husband and children have felt betrayed by what they see as a medical establishment that secretly experimented on and exploited black patients. Some of Lacks’ relatives wonder why they shouldn’t get a cut from what is still one of the world’s most popular—and profitable—cell lines: All the HeLa cells ever made would weigh 22 tons; a single vial can sell for nearly $10,000.

Skloot spends nearly 10 years earning the trust of Lacks’ daughter Deborah, who’s also obsessed with learning more about her mother. She still runs up against the Lackses’ understandable suspicion, such as when Deborah slams her up against a wall and asks if she’s really working for Johns Hopkins—but Skloot persists, intent on paying homage to the flesh-and-blood woman behind HeLa.


If you buy a book using our Bookshop link, a small share of the proceeds supports our journalism.

BEFORE YOU CLICK AWAY!

December is make or break for us. A full one-third of our annual fundraising comes in this month alone. A strong December means our newsroom is on the beat and reporting at full strength. A weak one means budget cuts and hard choices ahead.

The December 31 deadline is closing in fast. To reach our $400,000 goal, we need readers who’ve never given before to join the ranks of MoJo donors. And we need our steadfast supporters to give again today—any amount.

Managing an independent, nonprofit newsroom is staggeringly hard. There’s no cushion in our budget—no backup revenue, no corporate safety net. We can’t afford to fall short, and we can’t rely on corporations or deep-pocketed interests to fund the fierce, investigative journalism Mother Jones exists to do.

That’s why we need you right now. Please chip in to help close the gap.

BEFORE YOU CLICK AWAY!

December is make or break for us. A full one-third of our annual fundraising comes in this month alone. A strong December means our newsroom is on the beat and reporting at full strength. A weak one means budget cuts and hard choices ahead.

The December 31 deadline is closing in fast. To reach our $400,000 goal, we need readers who’ve never given before to join the ranks of MoJo donors. And we need our steadfast supporters to give again today—any amount.

Managing an independent, nonprofit newsroom is staggeringly hard. There’s no cushion in our budget—no backup revenue, no corporate safety net. We can’t afford to fall short, and we can’t rely on corporations or deep-pocketed interests to fund the fierce, investigative journalism Mother Jones exists to do.

That’s why we need you right now. Please chip in to help close the gap.

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate